Skip Navigation


Annals of Occupational Hygiene Advance Access originally published online on July 13, 2006
Annals of Occupational Hygiene 2006 50(6):638-639; doi:10.1093/annhyg/mel037
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
50/6/638    most recent
mel037v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by MAGE, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MAGE, D. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author 2006. Published by Oxford University Press on behalf of the British Occupational Hygiene Society


LETTERS TO THE EDITOR

Dermal Absorption of Chlorpyrifos

Geer et al. (2004) provided an interesting comparison between passive dosimetry measures and biomonitoring for chlorpyrifos (CP) exposure in pesticide workers. However, they made a questionable assumption of a 3% dermal absorption factor (DAF) for CP, stating: ‘[The] study by Nolan et al. (1984), supports the use of a 3% DAF, the Environmental Protection Agency (EPA) accepted value, whereas Krieger (1995) supports a 10% DAF and Griffin et al. (1999) report a 1% DAF.’ Thus they appear to treat the differences in these three values of 1, 3 and 10% as if they are caused by experimental error because they failed to recognize that the time of exposure is a determining factor for the CP DAF.

Examination of the study by Krieger (1995) shows no experimental data for CP DAF, only a generic range of 0.1–35%/24 h in his Table 2; Nolan et al. (1984) do not show a 3% DAF but a 1.3% average DAF for 12–20 h exposures; Griffin et al. (1995) report an average 1% DAF for an 8 h exposure (Table 1).


View this table:
[in this window]
[in a new window]

 
Table 1 Experimental CP DAF data of Nolan et al. (1984) and Griffin et al. (1995) where all subjects in each study received an identical amount of CP placed on their forearms

 
Apparently the 3% value quoted for Nolan et al. may have come from their abstract where they stated, ‘less than 3% of the dermal dose [of CP] was excreted in the urine’. EPA apparently took that 3% as the conservative upper estimate for DAF in a risk assessment process, but it is wrong to use it in Geer et al.’s study where they are estimating the actual amount of uptake to compare with urinary output.

Geer et al. report that in their modeled studies ‘Each worker was monitored once over a period of time representing a standard work shift [8 h] or duration of application ... Handwash samples were collected over the monitoring period during times when workers would typically wash their hands (i.e. before meals, before smoking, after using the bathroom, and at the end of the monitoring period) to assess surface deposition on the hands.’ Consequently Griffin's data would lead to an expectation that 1% of the hand loading at the start of the study would enter into the skin after 8 h, and assuming the subjects showered or bathed before going to sleep, some 12–20 h after their body exposure, the expectation from Nolan's data is that 1.3% would be absorbed into the skin. Consequently, the authors’ usage of 3% for a DAF is very likely to lead to a gross over-prediction of the amount entering the body.

Finally, the authors should have divided each subject's dosage in mg per day by the subject's body mass to provide their CP dosages in units of mg (kg day)–1, which could then be compared with EPA's reference dose (RfD) for CP. Failure to divide by body mass distorts these data because, when reported as mg per day, the surface loadings are multiplied by the subject's body surface area (BSA)—and that BSA increases with the subject's weight to the one-half power (Mosteller, 1987). Thus, if they divided their reported mg per day by the subject's weight, the effect of increasing body mass would be to decrease the mg (kg day)–1 as opposed to increasing the mg per day.

DAVID T. MAGE

Temple University (retired) Philadelphia, PA, USA E-mail: magedonner{at}aol.com

Received April 11, 2006;

REFERENCES

Geer LA, Cardello N, Dellarco MJ, et al. (2004) Comparative analysis of passive dosimetry, biomonitoring for assessing chlorpyrifos exposure in pesticide workers. Ann Occup Hyg 48:683–95.[Abstract/Free Full Text]

Griffin P, Mason H, Heywood K, et al. (1999) Oral and dermal absorption of chlorpyrifos: a human volunteer study. Occup Environ Med 56:10–3.[Abstract/Free Full Text]

Krieger RI. (1995) Pesticide exposure assessment. Toxicol Lett 82/83:65–72.

Mosteller RD. (1987) Simplified calculation of body-surface area. N Engl J Med 317:1098.[Web of Science][Medline]

Nolan RJ, Rick DL, Freshour NL, Saunders JH. (1984) Chlorpyrifos: pharmacokinetics in human volunteers. Toxicol Appl Pharmacol 73:8–15.[CrossRef][Web of Science][Medline]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
50/6/638    most recent
mel037v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by MAGE, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MAGE, D. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?